CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression

被引:202
|
作者
Carreno, BM
Bennett, F
Chau, TA
Ling, V
Luxenberg, D
Jussif, J
Baroja, ML
Madrenas, J
机构
[1] Univ Western Ontario, John P Robarts Res Inst, London, ON N6A 5K8, Canada
[2] Genet Inst Inc, Cambridge, MA 02140 USA
来源
JOURNAL OF IMMUNOLOGY | 2000年 / 165卷 / 03期
关键词
D O I
10.4049/jimmunol.165.3.1352
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CTLA-4 (CD152) engagement results in down-regulation of T cell activation. Two mechanisms have been postulated to explain CTLA-4 inhibition of T cell activation: negative signaling and competitive antagonism of CD28:B7-mediated costimulation, We assessed the contributions of these two mechanisms using a panel of T cell lines expressing human CTLA-4 with mutations in the cytoplasmic region. Under conditions of B7-independent costimulation, inhibition of IL-2 production following CTLA-4 engagement required the CTLA-4 cytoplasmic region. In contrast, under B7-dependent costimulation, inhibition of IL-2 production by CTLA-4 engagement was directly proportional to CTLA-4 cell surface levels and did not require its cytoplasmic region. Thus, CTLA-4 down-regulates T cell activation by two different mechanisms-delivery of a negative signal or B7 sequestration-that are operational depending on the levels of CTLA-4 surface expression. These two mechanisms may have distinct functional outcomes: rapid inhibition of T cell activation or induction of T cell anergy.
引用
收藏
页码:1352 / 1356
页数:5
相关论文
共 50 条
  • [41] CD28 and CTLA-4 control T cell activation through regulation of cbl-b expression.
    Li, DD
    Vermes, C
    Gál, I
    Finnegan, AG
    Mikecz, K
    Glant, TT
    Jian, Z
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S487 - S487
  • [42] Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist
    Fife, Brian T.
    Griffin, Matthew D.
    Abbas, Abul K.
    Locksley, Richard M.
    Bluestone, Jeffrey A.
    JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (08): : 2252 - 2261
  • [43] Predictive and prognostic significance of T cell surface CD28 and CTLA-4 levels in hemophilia
    Li, Lingling
    Li, Xiumin
    Liu, Kai
    Xue, Jie
    Wang, Dongni
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (09): : 6297 - 6305
  • [44] Differential role of CTLA-4 in regulation of resting memory versus naive CD4 T cell activation
    Metz, DP
    Farber, DL
    Taylor, T
    Bottomly, K
    JOURNAL OF IMMUNOLOGY, 1998, 161 (11): : 5855 - 5861
  • [45] Phenotypic analysis of CTLA-4 and CD28 expression during transient peptide-induced T cell activation in vivo
    Metzler, B
    Burkhart, C
    Wraith, DC
    INTERNATIONAL IMMUNOLOGY, 1999, 11 (05) : 667 - 675
  • [46] Impaired Butyrate Induced Regulation of T Cell Surface Expression of CTLA-4 in Patients with Ulcerative Colitis
    Magnusson, Maria K.
    Vidal, Alexander
    Maasfeh, Lujain
    Isaksson, Stefan
    Malhotra, Rajneesh
    Olsson, Henric K.
    Ohman, Lena
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (06) : 1 - 11
  • [47] Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) can regulate dendritic cell-induced activation and cytotoxicity CD8+ T cells independently of CD4+ T cell help
    McCoy, KD
    Hermans, IF
    Fraser, JH
    Le Gros, G
    Ronchese, F
    JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (07): : 1157 - 1162
  • [48] Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy
    Wells, AD
    Walsh, MC
    Bluestone, JA
    Turka, LA
    JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (06): : 895 - 903
  • [49] CTLA-4 ligation blocks CD-dependent T cell activation (vol 183, pg 2541, 1996)
    Walunas
    JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (01): : 301 - 301
  • [50] CD28/CTLA-4 RECEPTOR STRUCTURE, BINDING STOICHIOMETRY AND AGGREGATION DURING T-CELL ACTIVATION
    LINSLEY, PS
    LEDBETTER, J
    PEACH, R
    BAJORATH, J
    RESEARCH IN IMMUNOLOGY, 1995, 146 (03): : 130 - 140